tapentadol

(redirected from Nucynta)
Also found in: Medical.
Related to Nucynta: Nucynta ER
Translations

tapentadol

n tapentadol m
References in periodicals archive ?
PUERTO RICO SUPPLY UPDATE: Results for Q4 were negatively impacted by shortages of certain dosage strengths of Nucynta ER.
M2 PHARMA-December 6, 2017-The GrAaAaAeAa1/4nenthal Group announces new partnersh for the commercialisation of Nucynta in the US territory
M2 EQUITYBITES-December 6, 2017-The GrAaAaAeAa1/4nenthal Group announces n partnership for the commercialisation of Nucynta in the US territory
which makes Duragesic and Nucynta, in New Brunswick, New Jersey; Skadden, Arps, Slate, Meagher & Flom and Wiggin and Dana represent OxyContin and Dilaudid maker Purdue Pharma Inc.
divestiture of Nucynta (tapentadol) and lower sales of Risperdal Consta (risperidone).
The company also accused Horizon of opportunistically timing its takeover proposal: In April, Depomed publicly announced that it would re-launch our recently acquired NUCYNTA franchise in June 2015.
rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc.
Nucynta is an opioid and listed as a schedule II drug, meaning it has a high potential for abuse, and users may become psychologically or physically dependent on the drug.
Nucynta (tapentadol) CII is now available in 50-mg, 75-mg, and 100-mg tablets for the treatment of moderate to severe acute pain in patients 18 years and older.
tapentadol), Nucynta ER extended-release tablets, and Nucynta oral
M2 PHARMA-April 7, 2015-Depomed completes acquisition of US licence rights to Nucynta franchise from Janssen Pharmaceuticals
Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic taken twice daily, for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.